1. X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL. Issue 1 (23rd November 2022) Authors: Carlet, Michela; Schmelz, Karin; Vergalli, Jenny; Herold, Tobias; Senft, Daniela; Jurinovic, Vindi; Hoffmann, Thomas; Proba, Jutta; Weichert, Nina; Junghanß, Christian; Roth, Mareike; Eschenburg, Georg; Barz, Malwine; Henze, Günter; Eckert, Cornelia; Eggert, Angelika; Zuber, Johannes; Hundsdoerfe... Journal: EMBO molecular medicine Issue: Volume 15:Issue 1(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗